Next Health — Aventura
$$Aventura, FL, USA
Miami-area clinic with EBOO, plasma exchange, stem cells, IV therapy, and biomarker testing
Advanced DiagnosticsHormone OptimizationRegenerative TherapiesPeptide Therapy
Next Health — Tampa
$$Coming Soon
Pre-launch Hyde Park location, opening as Florida's second outpost
202 North Rome Avenue, Suite 101Tampa, FL, USA
Amenities & highlights
Hyde park settingTampa bay franchise First
About
Next Health Tampa is a pre-launch location planned for 202 North Rome Avenue in Tampa's Hyde Park neighborhood. It is set to become the network's second Florida location after Aventura. No opening date, Google Business Profile, Yelp listing, hours, or local clinical team has been published yet. The current action path is the founding-member waitlist on the location page.
What to Know
Signature approach
Once open, Tampa should follow the standard Next Health clinic model: biomarker testing, consults, IV/NAD+ therapy, recovery services, and other treatment tracks under one brand. The exact service mix, walk-in policy, hours, and clinical staffing are still unpublished.
What sets them apart
- Tampa Bay entry. This will be the first Next Health serving the Tampa Bay market.
- Hyde Park address. North Rome Avenue places the clinic in one of South Tampa's more walkable neighborhood corridors.
- Newer-generation buildout. Tampa is expected after the brand's current franchise design standards are already in place.
Before You Book
- Not open yet. There is no published opening date, hours, Google listing, or review base.
- Use the waitlist. Founding-member signup is the only direct pre-launch channel on the location page.
- Use Aventura for Florida care now. Aventura is the only operational Florida Next Health until Tampa opens.
Services & Facility
Services
Advanced DiagnosticsHormone OptimizationRegenerative TherapiesPeptide TherapyIV Therapy & InfusionsAesthetic & Anti-Aging ProceduresWeight ManagementGenetic TestingExecutive Health Screens
Location map
Pricing
Starting at
$99/mo
$99/mo Medicine 4.0 membership (quarterly testing + consultations)
Typical annual investment
$3,000/yr - $8,000/yr
Membership range estimate before any optional add-ons.
What this range includesMembership tiers, testing cadence, and common add-on examples.
Active members often pay beyond the membership fee once testing and treatments are added. A practical annual range is about $3,000/yr - $8,000/yr before the $14,500 Executive Physical.
In practiceAdd-ons, payment details, and coverage limits.
Think of Next Health pricing in layers:
- Membership: $99/mo - $399/mo, or $1,188/yr - $4,788/yr before extras.
- Testing: the Baseline Test is $349, Galleri cancer screening is $1,185, and the Executive Physical is $14,500.
- Treatments: IV drips start around $199 while NAD+, EBOO, plasma exchange, aesthetics, and other protocols add separately.
A regular member using testing plus periodic treatments should expect roughly $3,000/yr - $8,000/yr before any Executive Physical. Next Health does not publish insurance or HSA/FSA support.
Other Next Health locations
5
Next Health — Bellevue
$$Bellevue, WA, USA
Hormone therapy, IV drips, cryotherapy, and biomarker diagnostics under one roof
Advanced DiagnosticsHormone OptimizationRegenerative TherapiesPeptide Therapy
Next Health — Boulder
$$Boulder, CO, USA
Colorado's first Next Health, with IV therapy, cryotherapy, hyperbaric oxygen, and biomarker testing
Advanced DiagnosticsHormone OptimizationRegenerative TherapiesPeptide Therapy
Next Health — Chicago
$$Chicago, IL, USA
A former Pharmaca Integrative Pharmacy running IV drips, hormones, and biomarker diagnostics
Advanced DiagnosticsHormone OptimizationRegenerative TherapiesPeptide Therapy
Next Health — Elk Grove
$$Elk Grove, CA, USA
South Sacramento clinic with IV therapy, hormone care, biomarker testing, and guided first visits
Advanced DiagnosticsHormone OptimizationRegenerative TherapiesPeptide Therapy
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.